Customized research for RLMD vs. FNAM!

All in one page research, scroll down. Compare two other stocks.

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

Done! Side by Side Research Below for RLMD vs. FNAM.


↗ Join Our Free Email Newsletter.




Your Mobile Phone Number:

Relmada Therapeutics, Inc. vs. Fona, Inc.

Industry Match! Industry of Both RLMD and FNAM:

Health Care/Life Sciences

RLMD
Data Last Updated: More than a wk ago

↻  Update Column 1 to Most Recent

Key Statistics

Cap: 395.304M


P/E: N/A

P/S: N/A

Q P/B: 66.1

Y Rev: -

Q Rev: -

Beta: -0.06

RLMD Share Stats

Outstanding Shares

14.67M

Float Shares

13.28M

Percent of Float Short

9.58%

RLMD Insider Stats

Percent Outstanding Insider Ownership

5.9%

Percent Outstanding Institution Ownership

4.81%

RLMD Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

RLMD in Pulse Portal

Stream of Posts

RLMD Symbol Page

Share RLMD Insights

Express Sentiment

'Buy' or 'Sell' RLMD

RLMD Profile

CEO

Dr. Sergio Traversa

Exchange

Nasdaq

Employees

4.00

About

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company. It engages in the development of d-methadone receptor antagonist, which is a chemical entity that addresses areas of high unmet medical need in the treatment of central nervous system diseases and...

RLMD Financials

Annual Financials

Income Statement

Revenue

-

Net Income

(17.32M)

Cash Flow Statement

Change in Cash / Investments

6.98M

Balance Sheet

Cash / Investments

9.22M

Short Term Debt

364,204

Long Term Debt

None

Total Current Assets

9.98M

Total Current Liabilities

2.61M

Total Assets

10.22M

Total Liabilities

2.61M

Stockholder Equity

7.61M

Quarterly Financials

Income Statement

Q Revenue

-

Q Net Income

(3.67M)

Cash Flow Statement

Q Change in Cash / Investments

(1.37M)

Balance Sheet

Q Cash / Investments

7.85M

Q Short Term Debt

255,925

Q Long Term Debt

None

Q Total Current Assets

8.3M

Q Total Current Liabilities

2.54M

Q Total Assets

8.51M

Q Total Liabilities

2.54M

Q Stockholder Equity

5.98M

RLMD Charts

10-Year Chart

RLMD 10-Year Chart

5-Year Chart

RLMD 5-Year Chart

1-Year Chart

RLMD 1-Year Chart

6-Month Chart

RLMD 6-Month Chart

3-Month Chart

RLMD 3-Month Chart

1-Month Chart

RLMD 1-Month Chart

1-Day Chart

RLMD 1-Day Chart

FNAM
Data Last Updated: More than 2 wks ago

↻  Update Column 2 to Most Recent

Key Statistics

Cap: 11.764M


P/E: N/A

P/S: 106.95

Q P/B: 3.4

Y Rev: 114,814

Q Rev: 32,722

Beta: -0.25

FNAM Share Stats

Outstanding Shares

N/A

Float Shares

3.57M

Percent of Float Short

N/A

FNAM Insider Stats

Percent Outstanding Insider Ownership

0%

Percent Outstanding Institution Ownership

0.17%

FNAM Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

FNAM in Pulse Portal

Stream of Posts

FNAM Symbol Page

Share FNAM Insights

Express Sentiment

'Buy' or 'Sell' FNAM

FNAM Profile

CEO

Mr. Steven Bryan Warnecke

Exchange

OTC

Employees

4.00

About

Evolutionary Genomics, Inc. engages in developing and marketing an interactive information and advertising service. Its gene portfolio includes soybean pest and disease resistance, tomato sweetness and salt tolerance, cotton project, rice yield, wheat stern rust resistance,...

FNAM Financials

Annual Financials

Income Statement

Revenue

114,814

Net Income

(1.1M)

Cash Flow Statement

Change in Cash / Investments

(748,837)

Balance Sheet

Cash / Investments

159,606

Short Term Debt

None

Long Term Debt

None

Total Current Assets

223,417

Total Current Liabilities

-

Total Assets

4.41M

Total Liabilities

971,903

Stockholder Equity

3.43M

Quarterly Financials

Income Statement

Q Revenue

32,722

Q Net Income

(156,321)

Cash Flow Statement

Q Change in Cash / Investments

(126,814)

Balance Sheet

Q Cash / Investments

254,008

Q Short Term Debt

None

Q Long Term Debt

None

Q Total Current Assets

296,874

Q Total Current Liabilities

19,523

Q Total Assets

4.43M

Q Total Liabilities

974,969

Q Stockholder Equity

3.46M

FNAM Charts

10-Year Chart

FNAM 10-Year Chart

5-Year Chart

FNAM 5-Year Chart

1-Year Chart

FNAM 1-Year Chart

6-Month Chart

FNAM 6-Month Chart

3-Month Chart

FNAM 3-Month Chart

1-Month Chart

FNAM 1-Month Chart

1-Day Chart

FNAM 1-Day Chart

 

 


Research

×
Stock Streams
Global Streams

UserStreamReactionsPulseStreamSpecStreamEchoStream
Stock Streams

Message BoardSpecStream TrendingTrending StocksTV Buzz

IPO Buzz (Pricings)IPO Buzz (Upcoming)Stocks Gapping HigherTrending Public Companies (Top Volume Generators)

Uplisted StocksNew 52-Week Highs (NASDAQ)New 52-Week Highs (NYSE)New 52-Week Highs (AMEX)

Technical IndicatorsUpgradesDowngradesRecent Earnings Surprises

Market Streams

Trending IndustriesETF's by SectorSectors Top to BottomCommodities

Economic IndicatorsStock ExchangesETF Movers
Premarket Streams

NASDAQ Premarket GainersNASDAQ Premarket LosersOverseas MarketsS&P Premarket Gainers & Losers

Morning Earning ReleasesFutures

After Hours Streams

After Hours GainersAfter Hours DeclinersAfter Hours Most ActiveAfter the Bell Earning Releases
Symbol Alert Streams

Market Cap MilestonesAbove Average VolumeCurrent Movers - GainersCurrent Movers - Decliners

Short Squeeze AlertsPrice to Earnings PE AlertsPrice to Sales PS AlertsPrice to Book PB Alerts

Insider Holding AlertsInstitutional Holding AlertsLow Float StocksProfitable or Not

Cash Flow PositiveHigh Beta Volatile Stocks

Media Streams

HeadlinesMedia BuzzEconomic NewsTop Stories
Social Streams

Pulse User 'Buys'Pulse User 'Sells'B/S Today Positive Sentiment MilestonesB/S Today Negative Sentiment Milestones

Stock Follower MilestonesStocks Followed by Users


Streams
Streams
            anon
   anon